Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area

International Journal of Cancer

Volumn 78, Issue 6, 1998, Pages 695-698

  Sturm, Patrick D J ^a   Baas, Inge O ^a   Clement, Marjon J ^a   Nakeeb, Attila ^b   Offerhaus, G Johan A ^a   Hruban, Ralph H ^b   Pitt, Henry A ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER INCIDENCE; CARCINOGENESIS; CLINICAL ARTICLE; ENDEMIC DISEASE; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MALE; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; UNITED STATES;

ADULT; AGED; CHOLANGIOCARCINOMA; FEMALE; GENES, P53; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; TUMOR SUPPRESSOR PROTEIN P53; WEST VIRGINIA;

EID: 0031796826     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981209)78:6<695::AID-IJC5>3.0.CO;2-8     Document Type: Article

References (21)

1. BAAS, I.O., MULDER, J.W., OFFERHAUS, G.J., VOGELSTEIN, B. and HAMILTON, S.R., An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol., 172, 5-12 (1994).
2. BAAS, I.O., VAN DEN BERG, P.M., MULDER, J.W., CLEMENT, M.J., SLEBOS, R.J., HAMILTON, S.R. and OFFERHAUS, G.J.A., Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms. J. Pathol., 178, 264-267 (1996).
3. BOS, J.L., ras oncogenes in human cancer: a review. Cancer Res., 49, 4682-4689 (1989).
4. BRASH, D.E., RUDOLPH, J.A., SIMON, J.A., LIN, A., MCKENNA, G.J., BADEN, H.P., HALPERIN, A.J. and PONTEN, J., A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. nat. Acad. Sci. (Wash.), 88, 10124-10128 (1991).
5. CHO, K.R. and VOGELSTEIN, B., Genetic alterations in the adenoma-carcinoma sequence. Cancer, 70, Suppl. 6, 1727-1731 (1992).
6. DIAMANTIS, I., KARAMITOPOULOU, E., PERENTES, E. and ZIMMERMANN, A., p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Hepatology, 22, 774-779 (1995).
7. HARRIS, C.C. and HOLLSTEIN, M., Clinical implications of the p53 tumor suppressor gene. New Engl. J. Med., 329, 1318-1327 (1993).
8. HRUBAN, R.H., VAN MANSFELD, A.D.M., OFFERHAUS, G.J.A., VAN WEERING, D.H.J., ALLISON, D.C., GOODMAN, S.N., KENSLER, T.W., BOSE, K.K., CAMERON, J.L. and BOS, J.L., K-ras oncogene activation in adenocarcinoma of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Amer. J. Pathol., 143, 545-554(1993).
9. KIBA, T., TSUDA, H., PAIROJKUL, C., INOUE, S., SUGIMURA, T. and HIROHASHI, S., Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand. Mol. Carcinogen., 8, 312-318 (1993).
10. LEVI S., URBANO-ISPIZUA, A., GILL, R., THOMAS, D.M., GILBERTSON, J., FOSTER, C. and MARSHALL, C.J., Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res., 51, 3497-3502 (1991).
11. MOTOJIMA, K., TSUNODA, T., KANEMATSU, T., NAGAYA, Y., URANO, T. and SHIKU, H., Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene. Ann. Surg., 214, 657-662 (1991).
12. NAKEEB, A., PITT, H.A., SOHN, T.A., COLEMAN, J., ABRAMS, R.A., PIANTADOSI, S., HRUBAN, R.H., LILLEMOE, K.D., YEO, C.J. and CAMERON, J.L., Cholangiocarcinoma: a spectrum of intrahepatic, perihilar and distal tumors. Ann. Surg., 224, 463-473 (1996).
13. PITT, H.A., DOOLEY, W.C., YEO, C.J. and CAMERON, J.L., Malignancies of the biliary tract (review). Curr. Probl. Surg., 32, 1-90 (1995).
14. PITT, H.A., ELLIOTT, E., MATANOSKI, G.M., ROIDAD, M. and COLEMAN, J., A cluster of cholangiocarcinoma in West Virginia. In: Abstract book. Inaugural world congress of the international hepato-pancreato-biliary association, May 31-June 3, 1994, Boston, MA 25, F44, International Hepato-Biliary Pancreatic Association/World Association of Hepato-Pancreato-Biliary Surgery, Manchester, MA (1994).
15. SLEBOS, R.J.C., HRUBAN, R.H., DALESIO, O., MOOI, W.J., OFFERHAUS, G.J. and RODENHUIS, S., Relationship between K-ras activation and smoking in adenocarcinoma of the human lung. J. nat. Cancer Inst., 83, 1024-1027 (1991).
16. SRIVATANAKUL, P., OHSHIMA, H., KHLAT, M., PARKIN, M., SUKARYODHIN, S., BROUET, I. and BARTSCH, H., Opisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in Thailand. Int. J. Cancer, 48, 821-825 (1991).
17. TADA, M., YOKOSUKA, O., OMATA, M., OHTO, M. and ISONO, K., Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer, 66, 930-935 (1990).
18. TEH, M., WEE, A. and RAJU, G.C., An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinoma. Cancer, 74, 1542-1545 (1994).
19. VOGELSTEIN, B. and KINZLER, K.W., p53 function and dysfunction. Cell, 70, 523-526 (1992).
20. WASHINGTON, K. and GOTTFRIED, M.R., Expression of p53 in adenocarcinoma of the gallbladder and bile ducts. Liver, 16, 99-104 (1996).
21. WATANABE, M., ASAKA, M., TANAKA, J., KUROSAWA, M., KASAI, M. and MIYAZAKI, T., Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology, 107, 1147-1153 (1994).